(Q42513501)

1 November 2017

title

Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin (English)

1 reference

polycystic ovary syndrome

1 November 2017

0 references

1 reference

1 reference

1 reference

Koivunen RM

1

1 reference

1 November 2017

Morin-Papunen LC

2

1 reference

1 November 2017

Ruokonen A

3

1 reference

1 November 2017

Tapanainen JS

4

1 reference

1 November 2017

Martikainen HK

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

1 November 2017

1 reference

1 November 2017

volume

16

1 reference

1 November 2017

issue

12

1 reference

1 November 2017

page(s)

2546-2551

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

The polycystic ovary syndrome: pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

A simple measure of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Oestradiol feedback stimulation of androgen biosynthesis by human theca cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Insulin regulation of human ovarian androgens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

The gonadotropic function of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Leydig Cell Responsiveness to Single and Repeated Human Chorionic Gonadotropin Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Steroidogenic response to a single injection of hCG in pre- and early pubertal cryptorchid boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F16.12.2546

10.1093/HUMREP/16.12.2546

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference